Page 15 - Neurosciences Program Phd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Neurosciences program phd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Neurosciences Program Phd Today - Breaking & Trending Today

ProMIS Neurosciences initiates commercialization of COVID-19 serology assay

ProMIS Neurosciences initiates commercialization of COVID-19 serology assay
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Neutralizing Antibodies , Bowen Dempsey , Pharmaceutical Companies , Neurodegenerative Diseases , Government Organizations , Promis Neurosciences , Drug Discovery , Biotechnology Company ,

ProMIS Neurosciences Inc.: ProMIS Neurosciences initiates commercialization of COVID-19 serology assay


ProMIS Neurosciences Inc.: ProMIS Neurosciences initiates commercialization of COVID-19 serology assay
Seasoned industry executive and entrepreneur, Owen Dempsey to lead the effort for ProMIS
TORONTO and CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) ProMIS Neurosciences, Inc. (TSX: PMN); (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics selectively targeting toxic oligomers implicated in the development of neurodegenerative diseases, today announced that it has initiated commercialization of its COVID-19 serology assay and has appointed Owen Dempsey to lead the commercialization program.
Owen s professional work for the past 25 years has been to build companies founded to discover and commercialize antibodies in applications including life science research, pharmaceutical drug discovery, clinical diagnostics and therapeutic treatment of cancer, AIDS and other serious illness. He has led private, venture-backed ....

United Kingdom , United States , Bowen Dempsey , Nicholas Rigopulos , Toronto Stock Exchange , Promis Neurosciences Inc , Life Science Diagnostics Association , Life Science , Collective Coordinates , Disease Specific Epitopes , Investor Relations , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , ஓவந் டெம்ப்சே , டொராண்டோ ஸ்டாக் பரிமாற்றம் , ப்ரோமிச் நரம்பியல் இன்க் , வாழ்க்கை அறிவியல் பரிசோதனை சங்கம் , வாழ்க்கை அறிவியல் , கூட்டு ஆய அச்சுகள் , முதலீட்டாளர் உறவுகள் ,

Researchers call for better support for disabled academics


Aspects of academia create barriers for people with disabilities, write Justin and Rachel Yerbury
Academic institutions need to do much more to support faculty members with disabilities and to create an environment in which they can thrive, argues a commentary published 18 May in the journal Trends in Neurosciences.
The paper was written by Professor Justin Yerbury, who has amyotrophic lateral sclerosis (ALS), and his wife, Dr Rachel Yerbury. Professor Yerbury is a cell and molecular neurobiologist at the University of Wollongong (UOW) and the Illawarra Health and Medical Research Institute (IHMRI). Dr Yerbury is a psychologist at UOW and a research affiliate at IHMRI. Her research examines how nature affects mental health and well-being. ....

Rachel Yerbury , Justin Yerbury , Justinj Yerbury , Rachelm Yerbury , Illawarra Health , Research Institute , University Of Wollongong , Australian National Health , Research Council Investigator Grant , Professor Justin Yerbury , Professor Yerbury , Medical Research Institute , Medical Research Council Investigator , Amyotrophic Lateral Sclerosis , Research Council , Medical Research , Mental Health , ஜஸ்டின் ஏற்புரி , இல்லவர்ற ஆரோக்கியம் , ஆராய்ச்சி நிறுவனம் , பல்கலைக்கழகம் ஆஃப் வாலாஂகஂக் , ஆஸ்திரேலிய தேசிய ஆரோக்கியம் , ஆராய்ச்சி சபை புலனாய்வாளர் மானியம் , ப்ரொஃபெஸர் ஜஸ்டின் ஏற்புரி , ப்ரொஃபெஸர் ஏற்புரி , மருத்துவ ஆராய்ச்சி நிறுவனம் ,